首页 | 本学科首页   官方微博 | 高级检索  
检索        

小鼠MIP-1α真核表达质粒的构建及在HSV-Ⅱ核酸疫苗中的应用
引用本文:邵文爱,李晓眠.小鼠MIP-1α真核表达质粒的构建及在HSV-Ⅱ核酸疫苗中的应用[J].细胞与分子免疫学杂志,2006,22(3):286-289.
作者姓名:邵文爱  李晓眠
作者单位:1. 汕头大学医学院微生物与免疫学教研室,广东,汕头,515031
2. 天津医科大学微生物学教研室,天津,300070
摘    要:目的:构建小鼠巨噬细胞炎性蛋白-1α(MIP-1α)的真核表达质粒,观察其作为分子佐剂对单纯疱疹病毒Ⅱ型(HSV-Ⅱ)DNA疫苗免疫效果的影响.方法:以LPS刺激RAW264.7细胞提取总RNA.采用RT-PCR扩增出MIP-1α基因的全部编码序列,利用克隆载体pUCm-T,将其亚克隆入pcDNA3中,构建出小鼠MIP-1α的真核表达质粒Pm;将其转染COS-7细胞,并用Boyden趋化小室法检测MIP-1α的生物学活性.然后用其与HSV-ⅡgD的DNA疫苗一起免疫BALB/c小鼠,检测免疫小鼠的特异性抗体、脾T细胞增殖反应及病毒攻击小鼠后对小鼠的保护率,观察MIP-1α对HSV-Ⅱ DNA疫苗免疫效果的影响.结果:成功构建了小鼠MIP-1α的重组真核表达质粒;免疫BALB/c小鼠发现,其作为分子佐剂可加强HSV-ⅡgDNA疫苗的免疫效果.结论:小鼠MIP-1α可作为HSV-Ⅱ gD DNA疫苗的分子佐剂,为研制新型有效的HSV-Ⅱ DNA疫苗提供一定的依据.

关 键 词:小鼠巨噬细胞炎性蛋白-1α(MIP-1α)  单纯疱疹病毒Ⅱ型(HSV-Ⅱ)DNA疫苗  分子佐剂
文章编号:1007-8738(2006)03-0286-04
收稿时间:2005-04-11
修稿时间:2005-10-08

Construction of recombinant eukaryotic expression plasmid of murine chemokine MIP-1α and coimmunization with HSV-Ⅱ DNA vaccine
SHAO Wen-ai,LI Xiao-mian.Construction of recombinant eukaryotic expression plasmid of murine chemokine MIP-1α and coimmunization with HSV-Ⅱ DNA vaccine[J].Journal of Cellular and Molecular Immunology,2006,22(3):286-289.
Authors:SHAO Wen-ai  LI Xiao-mian
Institution:1.Department of Microbiology and Immunology, Shantou University Medical College, Shantou 515031 ; 2. Department of Microbiology, Tianjin Medical University, Tianjin 300070, China
Abstract:AIM: To construct the recombinant eukaryotic expression plasmid of murine macrophage inflammatory protein-1alpha (MIP-1alpha) and investigate the effect of MIP-1alpha as an adjuvant on immune response induced by herpes simplex virus type II glycoprotein D (HSV-II gD) DNA vaccine. METHODS: Using total RNA from RAW264.7 cells stimulated with LPS, the whole code sequence of murine MIP-1alpha was amplified by RT-PCR and inserted into pcDNA3 at Hind III/Xba I restriction sites. The recombinant eukaryotic expression plasmid Pm was transiently expressed in COS-7 cells and its specificity was demonstrated by RT-PCR and Boyden chemotaxis chamber assay. BALB/c mice were immunized with gD DNA vaccine and/or MIP-1alpha, and the effect of MIP-1alpha on gD DNA vaccine was evaluated by detecting anti-HSV-II antibody, antigen-specific lymphoproliferative responses, and examining survival rates after mice were challenged intravaginally with HSV-II. RESULTS: The recombinant eukaryotic expression plasmid of murine MIP-1alpha was constructed, and it was revealed that immune responses of HSV-II gD DNA vaccine were enhanced by coimmunization with MIP-1alpha. CONCLUSION: The murine MIP-1alpha can be used as an adjuvant of HSV-II gD DNA vaccine.
Keywords:
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号